| Year |
Citation |
Score |
| 2015 |
Piepenbrink KH, Maldarelli GA, Martinez de la Peña CF, Dingle TC, Mulvey GL, Lee A, von Rosenvinge E, Armstrong GD, Donnenberg MS, Sundberg EJ. Structural and evolutionary analyses show unique stabilization strategies in the type IV pili of Clostridium difficile. Structure (London, England : 1993). 23: 385-96. PMID 25599642 DOI: 10.1016/J.Str.2014.11.018 |
0.603 |
|
| 2014 |
Jacobson JM, Yin J, Kitov PI, Mulvey G, Griener TP, James MN, Armstrong G, Bundle DR. The crystal structure of shiga toxin type 2 with bound disaccharide guides the design of a heterobifunctional toxin inhibitor. The Journal of Biological Chemistry. 289: 885-94. PMID 24225957 DOI: 10.1074/Jbc.M113.518886 |
0.369 |
|
| 2012 |
Hirota SA, Iablokov V, Tulk SE, Schenck LP, Becker H, Nguyen J, Al Bashir S, Dingle TC, Laing A, Liu J, Li Y, Bolstad J, Mulvey GL, Armstrong GD, MacNaughton WK, et al. Intrarectal instillation of Clostridium difficile toxin A triggers colonic inflammation and tissue damage: development of a novel and efficient mouse model of Clostridium difficile toxin exposure. Infection and Immunity. 80: 4474-84. PMID 23045481 DOI: 10.1128/Iai.00933-12 |
0.6 |
|
| 2011 |
Dingle TC, Mulvey GL, Armstrong GD. Mutagenic analysis of the Clostridium difficile flagellar proteins, FliC and FliD, and their contribution to virulence in hamsters. Infection and Immunity. 79: 4061-7. PMID 21788384 DOI: 10.1128/Iai.05305-11 |
0.646 |
|
| 2011 |
El-Hawiet A, Kitova EN, Kitov PI, Eugenio L, Ng KK, Mulvey GL, Dingle TC, Szpacenko A, Armstrong GD, Klassen JS. Binding of Clostridium difficile toxins to human milk oligosaccharides. Glycobiology. 21: 1217-27. PMID 21610194 DOI: 10.1093/Glycob/Cwr055 |
0.615 |
|
| 2011 |
Mulvey GL, Dingle TC, Fang L, Strecker J, Armstrong GD. Therapeutic potential of egg yolk antibodies for treating Clostridium difficile infection. Journal of Medical Microbiology. 60: 1181-7. PMID 21474614 DOI: 10.1099/Jmm.0.029835-0 |
0.616 |
|
| 2010 |
Dingle T, Mulvey GL, Humphries RM, Armstrong GD. A real-time quantitative PCR assay for evaluating Clostridium difficile adherence to differentiated intestinal Caco-2 cells. Journal of Medical Microbiology. 59: 920-4. PMID 20413620 DOI: 10.1099/Jmm.0.019752-0 |
0.612 |
|
| 2010 |
Hirota SA, Fines K, Ng J, Traboulsi D, Lee J, Ihara E, Li Y, Willmore WG, Chung D, Scully MM, Louie T, Medlicott S, Lejeune M, Chadee K, Armstrong G, et al. Hypoxia-inducible factor signaling provides protection in Clostridium difficile-induced intestinal injury. Gastroenterology. 139: 259-69.e3. PMID 20347817 DOI: 10.1053/J.Gastro.2010.03.045 |
0.401 |
|
| 2009 |
Kitova EN, Mulvey GL, Dingle T, Sinelnikov I, Wee S, Griener TP, Armstrong GD, Klassen JS. Assembly and stability of the shiga toxins investigated by electrospray ionization mass spectrometry. Biochemistry. 48: 5365-74. PMID 19400587 DOI: 10.1021/Bi9003155 |
0.599 |
|
| 2008 |
Dingle T, Wee S, Mulvey GL, Greco A, Kitova EN, Sun J, Lin S, Klassen JS, Palcic MM, Ng KK, Armstrong GD. Functional properties of the carboxy-terminal host cell-binding domains of the two toxins, TcdA and TcdB, expressed by Clostridium difficile. Glycobiology. 18: 698-706. PMID 18509107 DOI: 10.1093/Glycob/Cwn048 |
0.603 |
|
| 2005 |
Kitova EN, Daneshfar R, Marcato P, Mulvey GL, Armstrong G, Klassen JS. Stability of the homopentameric B subunits of shiga toxins 1 and 2 in solution and the gas phase as revealed by nanoelectrospray fourier transform ion cyclotron resonance mass spectrometry. Journal of the American Society For Mass Spectrometry. 16: 1957-68. PMID 16242954 DOI: 10.1016/J.Jasms.2005.07.016 |
0.307 |
|
| Show low-probability matches. |